FDA Proposes Study to Assess the Use of Social Media in Conveying Risks to Patients
Will the FDA's proposed study on links end up allowing the one-click rule for digital medical device, pharma, and life sciences marketing?
The FDA's newly proposed study intends to look at whether links in "character-space-limited communications" can be effective and are sufficient at conveying important risk information to patients.
The so-called one-click rule, which is not an actual rule, but a common way to refer to its use, would allow companies to use links to an outside website to present safety information, instead of having to put the information within the advertisement. Currently, the FDA mandates all risk information be contained within the ad, which can difficult in space-limiting social media vehicles like Twitter and search ads.
Read more here: